The Niva Bupa Health Insurance IPO is set to open for subscription from November 6 to November 8, 2024. It comprises a fresh issue of ₹800 crore and an Offer for Sale (OFS) of ₹1,400 crore, making the total issue size ₹2,200 crore. The funds raised will be used to enhance the company’s capital base, improve solvency ratios, and meet general corporate expenses.

Key IPO Details:

• Price Band: ₹70–₹74 per share.
• Lot Size: 200 shares (minimum investment ₹14,800).
• Listing: Expected on November 13, 2024, on NSE and BSE.
• Promoter Stake: Pre-IPO, promoters hold 89.07%, which will reduce to 73.44% post-IPO.

Financial Highlights:

• Revenue Growth: ₹4,118.63 crore in FY24, up from ₹2,859.24 crore in FY23.
• Profit After Tax: ₹81.85 crore in FY24, a significant increase from ₹12.54 crore in FY23.
• Gross Direct Premium Income: ₹5,494 crore in FY24, growing at a CAGR of 41.37% over the last two years.

Competitive Advantages:

• Niva Bupa is the third-largest standalone health insurer in India.
• Focus on technology and analytics to enhance customer service and reduce fraud.
• Strong growth in retail health Gross Written Premium (GWP) at a CAGR of 33.41% from FY22 to FY24.

This IPO is led by major managers like Axis Capital, ICICI Securities, Kotak Mahindra Capital, and others. Investors can apply via ASBA or UPI through brokers.